Altimmune, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Altimmune, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Altimmune, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$24.6M, a 53.4% decline year-over-year.
  • Altimmune, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$101M, a 24.6% decline year-over-year.
  • Altimmune, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$88.4M, a 4.41% decline from 2022.
  • Altimmune, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$84.7M, a 12.7% increase from 2021.
  • Altimmune, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$97.1M, a 98% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$101M -$24.6M -$8.58M -53.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$92.8M -$24.4M -$4.32M -21.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-08
Q4 2023 -$88.4M -$31.6M -$9.98M -46.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 -$78.5M -$20.7M +$2.85M +12.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 -$81.3M -$16.1M +$4.05M +20.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$85.4M -$20.1M -$644K -3.31% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-08
Q4 2022 -$84.7M -$21.7M +$2.23M +9.33% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 -$86.9M -$23.5M +$9.99M +29.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$96.9M -$20.1M +$4.72M +19% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$102M -$19.4M -$4.57M -30.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$97.1M -$23.9M -$13.3M -125% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-28
Q3 2021 -$83.8M -$33.5M -$15.7M -88.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$68.1M -$24.8M -$8.06M -48.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$60M -$14.9M -$11M -283% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$49M -$10.6M -$6.53M -159% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 -$42.5M -$17.8M -$6.83M -62.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 -$35.7M -$16.8M -$13.4M -395% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-09
Q1 2020 -$22.3M -$3.89M -$1.79M -85.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-09
Q4 2019 -$20.5M -$4.1M +$20.4M +83.3% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$40.9M -$10.9M -$8.59M -365% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$32.3M -$3.39M +$5.75M +62.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-09
Q1 2019 -$38.1M -$2.1M +$1.08M +33.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-09
Q4 2018 -$39.2M -$24.5M -$15.7M -178% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-27
Q3 2018 -$23.5M -$2.35M +$27.6M +92.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$51M -$9.14M -$6.03M -194% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-13
Q1 2018 -$45M -$3.17M +$1.41M +30.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-13
Q4 2017 -$46.4M -$8.83M -$86.6M -111% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $40.2M -$29.9M -$25.1M -524% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $65.3M -$3.11M -$1.49M -92.3% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $66.8M -$4.58M -$3.35M -273% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $70.2M $77.8M +$79M Oct 1, 2016 Dec 31, 2016 10-K 2017-03-14
Q3 2016 -$8.88M -$4.8M -$3.47M -262% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 -$5.41M -$1.62M +$724K +30.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$6.13M -$1.23M -$2.69M -184% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-03
Q4 2015 -$3.44M -$1.24M +$1.39M +52.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-14
Q3 2015 -$4.83M -$1.32M +$3.3M +71.4% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-14
Q2 2015 -$8.14M -$2.34M -$1.9M -433% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-14
Q1 2015 -$6.23M $1.46M +$3.72M Jan 1, 2015 Mar 31, 2015 10-K 2017-03-14
Q4 2014 -$9.96M -$2.63M +$1.8M +40.6% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-11
Q3 2014 -$11.8M -$4.63M -$683K -17.3% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-11
Q2 2014 -$11.1M -$439K +$797K +64.5% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-11
Q1 2014 -$11.9M -$2.26M -$147K -6.97% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-11
Q4 2013 -$11.7M -$4.42M -$3.15M -248% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-11
Q3 2013 -$8.56M -$3.95M -$3.73M -1744% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-11
Q2 2013 -$4.83M -$1.24M -$480K -63.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-11
Q1 2013 -$4.35M -$2.11M +$569K +21.2% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-11
Q4 2012 -$4.92M -$1.27M -$2.02M -269% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-11
Q3 2012 -$2.9M -$214K -$180K -539% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-11
Q2 2012 -$2.72M -$757K +$1.68M +69% Mar 31, 2012 Jun 30, 2012 10-Q 2012-08-07
Q1 2012 -$4.4M -$2.68M -$604K -29.1% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-11
Q4 2011 -$3.8M $749K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-14
Q3 2011 -$33.5K +$4.29M +99.2% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-14
Q2 2011 -$2.44M +$3.96M +61.9% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-14
Q1 2011 -$2.08M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-14
Q3 2010 -$4.33M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-09
Q2 2010 -$6.39M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.